Wrighton-Smith Peter 4
4 · Oxford Immunotec Global PLC · Filed May 12, 2020
Insider Transaction Report
Form 4
Wrighton-Smith Peter
DirectorChief Executive Officer
Transactions
- Purchase
Ordinary Shares
2020-05-08$10.75/sh+2,075$22,306→ 358,700 total - Purchase
Ordinary Shares
2020-05-11$11.45/sh+26,000$297,700→ 384,700 total - Purchase
Ordinary Shares
2020-05-12$11.56/sh+15,525$179,469→ 400,225 total
Footnotes (3)
- [F1]The price reported for the purchase on May 8, 2020 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.6700 to $10.8300 per share, inclusive. The reporting person undertakes to provide Oxford Immunotec Global PLC, or any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.
- [F2]The price reported for the purchase on May 11, 2020 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.1550 to $11.7500 per share, inclusive. The reporting person undertakes to provide Oxford Immunotec Global PLC, or any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (2) to this Form 4.
- [F3]The price reported for the purchase on May 12, 2020 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.5100 to $11.6400 per share, inclusive. The reporting person undertakes to provide Oxford Immunotec Global PLC, or any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (3) to this Form 4.